Two new holostan-type glycosides, holotoxin D 1 (1) and 25,26-dihydroxy-holotoxin A 1 (2), together with two known analogues, stichlorosides C 1 (3) and bivittoside D (4), were isolated from the sea cucumber Apostichopus japonicus Selenka. The structures of the new compounds were elucidated on the basis of detailed spectroscopic analysis. Glycosides 1 and 3 exhibited potent antifungal activity.
Sea cucumbers are well known in East Asia as potential sources of neutraceutical, pharmaceutical and cosmetic agents, providing a new biochemical research area [1] . These animals are reported to have a remarkably diversity of triterpene glycosides, which can roughly be divided into two groups: the holostane type, with an 18(20) lactone, and the non-holostane type, without the lactone. These substances usually have interesting cytotoxic and antifungal activities [2] . In an earlier publication we reported the isolation of five new triterpene glycosides, namely 26-nor-25-oxo-holotoxin A 1 , and holotoxins D-G, together with three known analogues, holotoxins A 1 and B, and cladoloside B from the sea cucumber Apostichopus japonicus Selenka (also identified as Stichopus japonicus Selenka), which is a popular edible species, considered as a remedy similar to that of ginseng in China [3] . Our continuous investigation of the trace compounds of this animal led to the isolation of an additional two new holostane type glycosides hotoloxin D 1 (1) and 25,26-hydroxy-holotoxin A 1 (2) , along with two known glycosides, stichlorosides C 1 (3) , and bivittoside D (4) ( Figure 1 ). We herein report the isolation, structure elucidation, and bioactivity of these compounds.
The ethanol extract of dried A. japonicus was sequentially subjected to column chromatography on a hydrophobic resin and silica gel, followed by reversed-phase semi-preparative HPLC to give pure compounds 1-4. Structures of the glycosides were elucidated by extensive spectroscopic analysis, including 1D ( 1 H, 13 double bond (δ C 145.9, 110.7; δ H 4.90, 2H, s). The structure of the aglycone as holosta-9(11),25(26)-dien-16-one was also confirmed by 2D NMR spectroscopic data. Their difference was recognized in the sugar moieties.
The sugar moieties of 1 consisted of six monosaccharide residues as deduced from the 13 . The ESI-MS/MS experiment showed further proof by peaks for fragment ions at m/z:
. The above evidence led to the structure of holotoxin
25,26-Dihydroxy-holotoxin A 1 (2) was obtained as colorless powder. The molecular formula was established as C 66 H 106 O 33 by HR-ESI-MS from the pseudo-molecular ion at m/z 1446.6408 [M+Na] + . The 1 H and 13 C NMR spectra of the aglycone of 2 revealed a remarkable similarity to those of 1, except that the 25(26) terminal double bond (δ C 145.9, C, and 110.7, CH 2 ; δ H 4.90, 2H) [3, 5] in 1 was replaced by two hydroxyl groups in 2 ( Table 1 ). The hydroxyl groups were assigned at C-25 (δ C 72.6, C) and C-26 (δ C 70.6, δ H 3.91-3.95 m, or 4.03-4.07 m) due to the obvious HMBC correlations from H 3 -27 (δ H 1.59 or 1.64, s) to both C-25 and C-26. Slight variation of signals was noticed only at H-26 (δ H 3.91-3.95 m, or 4.03-4.07 m, 1:1) and H 3 -27 (δ H 1.59 or 1.64, s, 1:1), suggesting 2 to be a mixture of 25S and 25R isomers with a ratio of 1:1. The substructure of the aglycon part of 2 was then elucidated as holosta-9(11)-en-16-one-3β,25,26-triol. Figure 1) . Finally, the structure of 2 was established as 3β-O- 
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The isolation of the four triterpene glycosides, along with the earlier reported eight glycoside derivatives [3] from A. japonicus demonstrates a beautiful example of chemical diversity, extending the triterpene glycoside family by derivatives formed by carbon degradation, double bond transformation, and the nature of lactonization in the aglycone parts, and variation in the type and number of saccharides, as well as their interglycosidic linkages in the sugar moieties. The biogenetic relationship between the glycosides is obvious. In fact, both the non-holostane triterpene glycosides, holotoxins F and G, belong to the cluster of lanosteroltype glycosides. The co-isolation of holotoxin F and the lactonization product cladoloside B supports the hypothesis that lanosterol glycosides may act as a putative biosynthetic precursor to holostane triterpene glycosides [6] . The oxidation on CH 3 -18, followed by a lactonization with 20-hydroxy in lanosterol glycosides leads to the formation of an 18(20) lactone in the holostane triterpene glycosides. The 25,26-dihydroxy-holotoxin A 1 may derive from holotoxin A 1 by hydroxyl addition on the 26-terminal double bond, while the nortriterpene glycoside 26-nor-25-oxo-holotoxin A 1 [3] may be produced by the subsequent oxidative cleavage of the neighboring hydroxyls in 25,26-dihydroxyholotoxin A 1 .
In vitro antifungal activities of triterpene glycosides 1-3 were tested against six fungal stains (Table 3) . Itraconazole (ICZ), Terbenifine (TRB), Ketoconazole (KCZ), Amphotericin B (AMB), Voriconazole (VCZ) and Fluconazole (FCZ) were used as positive controls. Glycosides 1 and 3 exhibited significant growth inhibitory activity against six strains, with MIC 80 values of 1.4-22.3 μM (Table 3) , while compound 2 only showed weak antifungal activity against Cryptococcus neoformans and Aspergillus fumigatus. These facts further support the previous conclusion that the Δ 25 terminal double bond may increase the activity [3] . [α] 
Antifungal susceptibility test:
The antifungal activities of glycosides 1-3 were tested against 6 strains: Candida albicans SC5314, Cryptococcus neoformans BLS108, Candida tropicalis, Trichophyton rubrum 0501124, Microsporum gypseum 31388 and Aspergillus fumigatus 0504656. The data of antifungal activities were evaluated by measuring optical density (OD) at 630 nm using an Automatic Microplate Reader [7] . The drug MIC 80 was defined as the first well with an approximate 80% reduction in growth compared with the growth of the drug-free-well. For each fungus strain and drug concentration, the assay was performed for 3 biological replicates and each with 3 technical replicates.
Itraconazole (ICZ), Terbenifine (TRB), Ketoconazole (KCZ), Amphotericin B (AMB), Voriconazole (VCZ) and Fluconazole (FCZ) were used as positive controls.
